ArticleHepatitis monthly2013

Assessment of viral genotype impact to the cost-effectiveness and overall costs of care for PEG-interferon-2α + ribavirine treated chronic hepatitis C patients.

Mihajlo Jakovljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.